Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy

Diabetic Medicine

Volumn 20, Issue 4, 2003, Pages 277-282

  Yuyun, M F ^a   Dinneen, S F ^a   Edwards, O M ^a   Wood, E ^a   Wareham, Nicholas J ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Albuminuria; Cardiovascular disease; Diabetes mellitus; Mortality; Nephropathy

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DISEASE MARKER; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RISK ASSESSMENT;

ADULT; ALBUMINURIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0038813682     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00940.x     Document Type: Article

References (34)

1. Deckert TH, Yokoyama E, Mathiesen B, Ronn T, Jensen B, Feldt Rasmussen K et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. Br Med J 1996; 312: 871-874.
2. Tuomilehto J, Borch JK, Molarius A, Forsen T, Rastenyte D, Sarti C et al. Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 1998; 41: 784-790.
3. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC et al. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 1987; 59: 750-755.
4. Earle KA, Mishra M, Morocutti A, Barnes D, Stephens E, Chambers J et al. Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. Diabetologia 1996; 39: 854-856.
5. Rossing P, Hougaard P, Borch Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. Br Med J 1996; 313: 779-784.
6. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993; 16: 996-1003.
7. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360.
8. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med 1984; 1: 17-19.
9. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997; 80: 164-169.
10. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995; 38: 610-616.
11. Gall MA, Borch Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995; 44: 1303-1309.
12. Mattock MB, Barnes DJ, Viberti G, Keen H, Burt D, Hughes JM et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 1998; 47: 1786-1792.
13. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Den Ottolander GJH. Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323.
14. Beatty OL, Ritchie CM, Bell PM, Hadden DR, Kennedy L, Atkinson AB. Microalbuminuria as identified by a spot morning urine specimen in non-insulin-treated diabetes: an eight-year follow-up study. Diabet Med 1995; 12: 261-266.
15. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418.
16. Bigazzi R, Bianchi S, Baldari D, Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325-1333.
17. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; 2: 530-533.
18. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
19. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300.
20. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.
21. Borch Johnsen K, Feldt Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997.
22. Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259.
23. Parving HH, Hommel E, Jensen BR, Hansen HP. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int 2001; 60: 228-234.
24. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captcpril Study Group. JAMA 1994; 271: 275-279.
25. Spoelstra-De Man AME, Brouwer CB, Stehouwer CDA, Smulders YM. Rapid progression of albumin excretion is an independent predictor of cardiovascular mortality in patients with type 2 diabetes and microabuminuria. Diabetes Care 2001; 24: 2097-2101.
26. Rachmani R, Levi Z, Lïdar M, Slavachevski I, Half Onn E, Ravid M. Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients. Diabetes Res Clin Pract 2000; 49: 187-194.
27. Marshall SM. Screening for microalbuminuria: which measurement? Diabet Med 1991; 8: 706-711.
28. Sandercock P, Molyneaux A, Warlow C. Value of computerised tomography in patients with stroke: the Oxfordshire Community Stroke Project. Br Med J 1985; 290: 193-197.
29. Parving HH, Lehnert H, Brochner Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
30. Almdal T, Norgaard K, Feldt Rasmussen B, Deckert T. The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 1994; 17: 120-125.
31. Forsblom CM, Groop PH, Ekstrand A, Totterman KJ, Sane T, Saloranta C et al. Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 1998; 21: 1932-1938.
32. Deckert T, Feldt Rasmussen B, Borch Johnsen K, Jensen T, Kofoed Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226.
33. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGM. Microalbuminuria and associated cardiovascular risk factors in the community. Atheriosclerosis 1992; 93: 71-81.
34. Bennett PH, Lee ET, Lu M, Keen H, Fuller JH. Increased urinary albumin excretion and its associations in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44: S37-45.